Natural Biocon (India) Limited (BOM:543207)
India · Delayed Price · Currency is INR 3.810
+0.110 (2.97%)
At close: Aug 14, 2026
Natural Biocon (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 8.78 | 25.44 | 83.48 | 135.34 | 12.54 | 4.82 |
Other Revenue | 0.01 | 0.01 | - | - | - | - |
| 8.8 | 25.45 | 83.48 | 135.34 | 12.54 | 4.82 | |
Revenue Growth | -90.25% | -69.51% | -38.32% | 978.97% | 160.34% | 265.24% |
Cost of Revenue | 7.05 | 21.75 | 73.94 | 126.69 | 8.79 | 2.88 |
Gross Profit | 1.74 | 3.7 | 9.54 | 8.65 | 3.75 | 1.94 |
Selling, General & Admin | 1.52 | 1.75 | 4.54 | 3.51 | 0.81 | 0.28 |
Other Operating Expenses | 2.09 | 2.32 | 4.39 | 2.88 | 0.46 | 0.78 |
Operating Expenses | 3.65 | 4.1 | 8.94 | 6.38 | 1.27 | 1.06 |
Operating Income | -1.9 | -0.4 | 0.61 | 2.26 | 2.48 | 0.89 |
Other Non Operating Income (Expenses) | - | - | -0.01 | -0.01 | -0.01 | -0.01 |
Pretax Income | -1.9 | -0.4 | 0.6 | 2.25 | 2.47 | 0.88 |
Income Tax Expense | - | - | 0.15 | 0.73 | 0.68 | 0.22 |
Net Income | -1.9 | -0.4 | 0.45 | 1.53 | 1.79 | 0.66 |
Net Income to Common | -1.9 | -0.4 | 0.45 | 1.53 | 1.79 | 0.66 |
Net Income Growth | - | - | -70.77% | -14.77% | 171.77% | 2296.71% |
Shares Outstanding (Basic) | - | 20 | 21 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | - | 20 | 21 | 11 | 11 | 11 |
Shares Change | - | -4.67% | 84.47% | - | - | - |
EPS (Basic) | - | -0.02 | 0.02 | 0.13 | 0.16 | 0.06 |
EPS (Diluted) | - | -0.02 | 0.02 | 0.13 | 0.16 | 0.06 |
EPS Growth | - | - | -84.62% | -17.45% | 171.77% | 2297.39% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 0.12 | 12.97 | -1.25 | 2.1 | 1.94 |
Free Cash Flow Per Share | - | 0.01 | 0.62 | -0.11 | 0.18 | 0.17 |
Gross Margin | 19.82% | 14.54% | 11.43% | 6.39% | 29.93% | 40.33% |
Operating Margin | -21.62% | -1.57% | 0.73% | 1.67% | 19.79% | 18.41% |
Profit Margin | -21.62% | -1.57% | 0.53% | 1.13% | 14.28% | 13.68% |
Free Cash Flow Margin | - | 0.48% | 15.53% | -0.92% | 16.77% | 40.29% |
EBITDA | -1.86 | -0.37 | 0.61 | - | - | - |
EBITDA Margin | -21.15% | -1.44% | 0.73% | - | - | - |
D&A For EBITDA | 0.04 | 0.03 | 0.01 | - | - | - |
EBIT | -1.9 | -0.4 | 0.61 | 2.26 | 2.48 | 0.89 |
EBIT Margin | -21.62% | -1.57% | 0.73% | 1.67% | 19.79% | 18.41% |
Effective Tax Rate | - | - | 25.16% | 32.24% | 27.50% | 25.03% |
Revenue as Reported | 8.8 | 25.45 | 83.48 | 135.34 | 12.54 | 4.82 |
Advertising Expenses | - | - | 0.02 | 0.01 | - | 0.02 |